My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 258

    1.

    Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.

    Padoa CJ, Banga JP, Madec AM, Ziegler M, Schlosser M, Ortqvist E, Kockum I, Palmer J, Rolandsson O, Binder KA, Foote J, Luo D, Hampe CS.

    Diabetes. 2003 Nov;52(11):2689-95.PMID: 14578287 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Multiplicity of the antibody response to GAD65 in Type I diabetes.

    Gilliam LK, Binder KA, Banga JP, Madec AM, Ortqvist E, Kockum I, Luo D, Hampe CS.

    Clin Exp Immunol. 2004 Nov;138(2):337-41.PMID: 15498046 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.

    Schlosser M, Banga JP, Madec AM, Binder KA, Strebelow M, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS.

    Diabetologia. 2005 May;48(5):922-30. Epub 2005 Apr 16.PMID: 15834701 [PubMed - indexed for MEDLINE]Related articles

    4.

    Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

    Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9.PMID: 11134126 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11.

    Fenalti G, Hampe CS, O'connor K, Banga JP, Mackay IR, Rowley MJ, El-Kabbani O.

    Mol Immunol. 2007 Feb;44(6):1178-89. Epub 2006 Aug 22.PMID: 16930708 [PubMed - indexed for MEDLINE]Related articles

    6.

    Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.

    Hampe CS, Nalini R, Maldonado MR, Hall TR, Garza G, Iyer D, Balasubramanyam A.

    J Clin Endocrinol Metab. 2007 Feb;92(2):462-7. Epub 2006 Nov 7.PMID: 17090641 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.

    Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, Ortqvist E, Hampe CS.

    J Immunol. 2005 Dec 1;175(11):7755-62.PMID: 16301686 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.

    Maioli M, Alejandro E, Tonolo G, Gilliam LK, Bekris L, Hampe CS, Obinu DA, Manconi A, Puddu L, Lynch K, Lernmark A; Study Group for the Genetics of Diabetes in Sardinia.

    J Clin Endocrinol Metab. 2004 Nov;89(11):5675-82.PMID: 15531528 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Epitope analysis of GAD65Ab using fusion proteins and rFab.

    Binder KA, Banga JP, Madec AM, Ortqvist E, Luo D, Hampe CS.

    J Immunol Methods. 2004 Dec;295(1-2):101-9. Epub 2004 Oct 30.PMID: 15627615 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.

    Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP.

    Clin Exp Immunol. 1999 Dec;118(3):349-56.PMID: 10594551 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.

    Hampe CS, Hall TR, Agren A, Rolandsson O.

    Clin Exp Immunol. 2007 Apr;148(1):72-8.PMID: 17286757 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.

    Hayakawa N, Premawardhana LD, Powell M, Masuda M, Arnold C, Sanders J, Evans M, Chen S, Jaume JC, Baekkeskov S, Smith BR, Furmaniak J.

    Autoimmunity. 2002 Aug;35(5):343-55.PMID: 12515289 [PubMed - indexed for MEDLINE]Related articles

    13.

    Conformation-dependent GAD65 autoantibodies in diabetes.

    Luo D, Gilliam LK, Greenbaum C, Bekris L, Hampe CS, Daniels T, Richter W, Marcovina SM, Rolandsson O, Landin-Olsson M, Kockum I, Lernmark A.

    Diabetologia. 2004 Sep;47(9):1581-91. Epub 2004 Sep 8.PMID: 15365614 [PubMed - indexed for MEDLINE]Related articles

    14.

    Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes.

    Jury K, Söhnlein P, Vogel M, Richter W.

    Diabetes. 2001 Sep;50(9):1976-82.PMID: 11522662 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.

    Ziegler B, Strebelow M, Rjasanowski I, Schlosser M, Ziegler M.

    Autoimmunity. 1998;28(2):61-8.PMID: 9771977 [PubMed - indexed for MEDLINE]Related articles

    16.

    Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles.

    Maruyama T, Oak S, Hall TR, Banga JP, Ortqvist E, Ettinger RA, Endl J, Hampe CS.

    Clin Exp Immunol. 2007 Dec;150(3):416-21. Epub 2007 Oct 22.PMID: 17956579 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Epitope analysis of insulin autoantibodies using recombinant Fab.

    Padoa CJ, Crowther NJ, Thomas JW, Hall TR, Bekris LM, Torn C, Landin-Olsson M, Ortqvist E, Palmer JP, Lernmark A, Hampe CS.

    Clin Exp Immunol. 2005 Jun;140(3):564-71.PMID: 15932520 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.

    Ziegler B, Schlosser M, Lühder F, Strebelow M, Augstein P, Northemann W, Powers AC, Ziegler M.

    Acta Diabetol. 1996 Sep;33(3):225-31.PMID: 8904930 [PubMed - indexed for MEDLINE]Related articles

    19.

    Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.

    Falorni A, Ackefors M, Carlberg C, Daniels T, Persson B, Robertson J, Lernmark A.

    Diabetologia. 1996 Sep;39(9):1091-8.PMID: 8877294 [PubMed - indexed for MEDLINE]Related articles

    20.

    Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.

    Falorni A, Gambelunghe G, Forini F, Kassi G, Cosentino A, Candeloro P, Bolli GB, Brunetti P, Calcinaro F.

    J Clin Endocrinol Metab. 2000 Jan;85(1):309-16.PMID: 10634404 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity